BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30362386)

  • 1. Assessment of the antiproliferative and apoptotic roles of sulfonamide carbonic anhydrase IX inhibitors in HeLa cancer cell line.
    Koyuncu I; Gonel A; Durgun M; Kocyigit A; Yuksekdag O; Supuran CT
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):75-86. PubMed ID: 30362386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells.
    Koyuncu I; Gonel A; Kocyigit A; Temiz E; Durgun M; Supuran CT
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1137-1149. PubMed ID: 30001631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells.
    Koyuncu I; Tülüce Y; Slahaddin Qadir H; Durgun M; Supuran CT
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):703-711. PubMed ID: 30810431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide - A new caspase-activating proapoptotic agent.
    Dar'in D; Kantin G; Kalinin S; Sharonova T; Bunev A; Ostapenko GI; Nocentini A; Sharoyko V; Supuran CT; Krasavin M
    Eur J Med Chem; 2021 Oct; 222():113589. PubMed ID: 34147910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors.
    Koyuncu I; Temiz E; Güler EM; Durgun M; Yuksekdag O; Giovannuzzi S; Supuran CT
    ChemMedChem; 2024 May; 19(9):e202300680. PubMed ID: 38323458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells.
    Temiz E; Koyuncu I; Durgun M; Caglayan M; Gonel A; Güler EM; Kocyigit A; Supuran CT
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34198834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel artemisinin-sulfonamidehybrids as potential carbonicanhydraseIX inhibitors with improved antiproliferative activities.
    An R; Lin B; Zhao S; Cao C; Wang Y; Cheng X; Liu Y; Guo M; Xu H; Wang Y; Hou Z; Guo C
    Bioorg Chem; 2020 Nov; 104():104347. PubMed ID: 33142414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEG Linker Length Strongly Affects Tumor Cell Killing by PEGylated Carbonic Anhydrase Inhibitors in Hypoxic Carcinomas Expressing Carbonic Anhydrase IX.
    Mondal UK; Doroba K; Shabana AM; Adelberg R; Alam MR; Supuran CT; Ilies MA
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
    Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
    Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfonamido carboranes as highly selective inhibitors of cancer-specific carbonic anhydrase IX.
    Dvořanová J; Kugler M; Holub J; Šícha V; Das V; Nekvinda J; El Anwar S; Havránek M; Pospíšilová K; Fábry M; Král V; Medvedíková M; Matějková S; Lišková B; Gurská S; Džubák P; Brynda J; Hajdúch M; Grüner B; Řezáčová P
    Eur J Med Chem; 2020 Aug; 200():112460. PubMed ID: 32505851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of carbonic anhydrase IX decreases cell proliferation and induces ceramide-mediated apoptosis in human cancer cells.
    Cianchi F; Vinci MC; Supuran CT; Peruzzi B; De Giuli P; Fasolis G; Perigli G; Pastorekova S; Papucci L; Pini A; Masini E; Puccetti L
    J Pharmacol Exp Ther; 2010 Sep; 334(3):710-9. PubMed ID: 20519553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.
    Zengin Kurt B; Sonmez F; Ozturk D; Akdemir A; Angeli A; Supuran CT
    Eur J Med Chem; 2019 Dec; 183():111702. PubMed ID: 31542715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated Bis-Sulfonamide Carbonic Anhydrase Inhibitors Can Efficiently Control the Growth of Several Carbonic Anhydrase IX-Expressing Carcinomas.
    Akocak S; Alam MR; Shabana AM; Sanku RK; Vullo D; Thompson H; Swenson ER; Supuran CT; Ilies MA
    J Med Chem; 2016 May; 59(10):5077-88. PubMed ID: 27144971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy.
    Andreucci E; Ruzzolini J; Peppicelli S; Bianchini F; Laurenzana A; Carta F; Supuran CT; Calorini L
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):117-123. PubMed ID: 30362384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization and biological evaluation of tertiary sulfonamide derivatives of pyridyl-indole based heteroaryl chalcone as potential carbonic anhydrase IX inhibitors and anticancer agents.
    Peerzada MN; Khan P; Ahmad K; Hassan MI; Azam A
    Eur J Med Chem; 2018 Jul; 155():13-23. PubMed ID: 29852328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer.
    Eldehna WM; Nocentini A; Al-Rashood ST; Hassan GS; Alkahtani HM; Almehizia AA; Reda AM; Abdel-Aziz HA; Supuran CT
    Bioorg Chem; 2018 Dec; 81():425-432. PubMed ID: 30219719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
    Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
    Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes.
    Gul HI; Yamali C; Bulbuller M; Kirmizibayrak PB; Gul M; Angeli A; Bua S; Supuran CT
    Bioorg Chem; 2018 Aug; 78():290-297. PubMed ID: 29621641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
    Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
    Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyridazinone-substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines.
    Krasavin M; Shetnev A; Baykov S; Kalinin S; Nocentini A; Sharoyko V; Poli G; Tuccinardi T; Korsakov M; Tennikova TB; Supuran CT
    Eur J Med Chem; 2019 Apr; 168():301-314. PubMed ID: 30826507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.